CME Group Inc. (NASDAQ:CME) Shares Bought by Vise Technologies Inc.

Vise Technologies Inc. grew its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 73.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,159 shares of the financial services provider's stock after buying an additional 2,182 shares during the quarter. Vise Technologies Inc.'s holdings in CME Group were worth $1,198,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the business. Norges Bank purchased a new stake in shares of CME Group during the fourth quarter valued at approximately $1,107,389,000. Price T Rowe Associates Inc. MD raised its position in shares of CME Group by 89.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock valued at $1,923,047,000 after purchasing an additional 3,921,278 shares during the period. Raymond James Financial Inc. bought a new stake in CME Group during the 4th quarter worth approximately $871,063,000. Capital Wealth Planning LLC increased its holdings in CME Group by 69.2% during the 4th quarter. Capital Wealth Planning LLC now owns 2,435,823 shares of the financial services provider's stock worth $565,671,000 after acquiring an additional 996,498 shares during the period. Finally, Egerton Capital UK LLP bought a new stake in CME Group during the 4th quarter worth approximately $223,967,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Charles P. Carey sold 3,000 shares of the company's stock in a transaction dated Thursday, May 15th. The shares were sold at an average price of $272.56, for a total transaction of $817,680.00. Following the transaction, the director now directly owns 5,400 shares in the company, valued at approximately $1,471,824. This represents a 35.71% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Hilda Harris Piell sold 3,984 shares of the company's stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $250.47, for a total transaction of $997,872.48. Following the transaction, the insider now owns 27,046 shares in the company, valued at $6,774,211.62. The trade was a 12.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 28,384 shares of company stock worth $7,531,053. 0.30% of the stock is currently owned by corporate insiders.

CME Group Price Performance

NASDAQ CME traded up $0.29 during trading on Tuesday, hitting $284.36. 1,792,736 shares of the stock traded hands, compared to its average volume of 2,190,079. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $286.48. The firm has a 50-day simple moving average of $268.20 and a 200-day simple moving average of $249.76. The company has a market capitalization of $102.47 billion, a P/E ratio of 29.41, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45.

CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. The firm had revenue of $1.64 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. CME Group's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the firm posted $2.50 earnings per share. As a group, analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th will be issued a $1.25 dividend. The ex-dividend date of this dividend is Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.76%. CME Group's dividend payout ratio (DPR) is presently 50.30%.

Wall Street Analysts Forecast Growth

CME has been the topic of a number of research analyst reports. Oppenheimer increased their price target on shares of CME Group from $269.00 to $279.00 and gave the stock an "outperform" rating in a report on Friday, April 11th. Royal Bank of Canada reissued a "sector perform" rating and issued a $269.00 price target on shares of CME Group in a report on Thursday, April 3rd. Piper Sandler upped their price objective on shares of CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a research note on Tuesday, April 8th. Raymond James raised shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price objective for the company in a research note on Monday, March 10th. Finally, Bank of America upped their price objective on shares of CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a research note on Wednesday, April 2nd. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $256.80.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.